Cordlife Group Limited · SGX:P8A

Cordlife — H1 2021 Earnings Presentation

20 slides from Cordlife's earnings presentation, 2021

  1. Slide 1: 1H2021 Results Presentation

    1H2021 Results Presentation

  2. Slide 2: Disclaimer

    Disclaimer This presentation does not constitute, or form any part of any offer for sale or subscription of, or solicitation of any offer to buy or subscribe for, any securities in Cordlife Group Limited (“Cordlife”) in Singapore or any other jurisdiction nor shall it or any part of it form the basi

  3. Slide 3: Content

    Content 1 Overview 2 Financial Highlights 3 Outlook & Growth Strategies 3

  4. Slide 4: Overview

    Overview 4

  5. Slide 5: Business Overview – Operating Segments

    Business Overview – Operating Segments BANKING CORD LINING MESENCHYMAL DIAGNOSTICS CORD BLOOD CORD LINING STEM CELLS DIGITAL HEALTHCARE OTHERS CORD LINING CORD TISSUE CORD TISSUE EPITHELIAL MESENCHYMAL STEM CELLS STEM CELLS

  6. Slide 6: Business Overview – Operating Segments

    Business Overview – Operating Segments PREIMPLANTATION NON-INVASIVE NEWBORN BANKING ENDOMETRIAL GENETIC PRENATAL METABOLIC DIAGNOSTICS RECEPTIVITY SCREENING TESTING SCREENING DIGITAL HEALTHCARE TEST MOMS UP OTHERS NEWBORN GENETIC LIFE SPROUTS GENETIC PAEDIATRIC PAEDIATRIC TALENT TEST SCREENING VISIO

  7. Slide 7: Business Overview – Market Presence

    Business Overview – Market Presence BANKING DIAGNOSTICS DIGITAL HEALTHCARE OTHERS Our Network Cordlife owns the largest network of cord blood banks in Asia with full stem cell banking facilities in six key markets namely Singapore, Hong Kong, Indonesia, India, Malaysia and the Philippines. In Singap

  8. Slide 8: Financial Highlights

    Financial Highlights cordlife .

  9. Slide 9: 1H2021 Results Summary

    1H2021 Results Summary REVENUE GROSS PROFIT GP MARGIN S$23.2 million S$14.7 million 63.2% (11.7)% y-o-y (11.0)% y-o-y +0.5 pp y-o-y NET PROFIT NET PROFIT MARGIN NET CASH1 S$2.5 million 10.8% S$73.4 million (5.2)% y-o-y (0.8)pp y-o-y (S$1.8) million from 31 Dec 20 1: Includes cash and cash equivalent

  10. Slide 10: Analysis of 1H2020

    Analysis of 1H2020 Revenue The Group’s revenue declined 11.7% year-on-year (“yoy”) to S$23.2 million due to a 17.0% yoy decrease in new samples processed and stored in 1H2021 arising from the outbreak of COVID-19. However, the decline was partially offset by the conversion of more clients to higher

  11. Slide 11: Financials – Revenue

    Financials – Revenue S$ mil % 80 70 61.4 61.6 60 51.5 50.6 50 40 30 26.2 23.2 20 10 0 FY2017 12M2018 FY2019 FY2020 1H2020 1H2021 11

  12. Slide 12: Financials – Quarter-on-quarter Revenue

    Financials – Quarter-on-quarter Revenue S$ mil 20 18 15.6 16.0 16 15.5 14.4 14.5 14 12.7 11.8 11.7 11.9 12 11.3 10 8 6 4 2 0 1Q2019 2Q2019 3Q2019 4Q2019 1Q2020 2Q2020 3Q2020 4Q2020 1Q2021 2Q2021 12

  13. Slide 13: Financials – Gross Profit

    Financials – Gross Profit S$ mil 90 80 70 64.5 % 62.5 % 62.7 % 62.7 % 63.2 % 58.9 % 60 50 38.3 39.7 40 31.7 30.3 30 20 16.5 14.6 10 0 FY2017 12M2018 FY2019 FY2020 1H2020 1H2021 Gross Profit Gross Profit Margin 13

  14. Slide 14: Financials – Operating profit after tax

    Financials – Operating profit after tax S$ mil 10 12.9 % 10.8 % 15.0 9 9.4 % 10.0% 8 1.0 % 2.0 % 0.0 7 6.6 6 5.8 -15.0 5 4 -30.0 3 2.6 2.5 2 -45.0 1.2 1 0.5 0 -60.0 FY2017 12M2018 FY2019 FY2020 1H2020 1H2021 Net Profit Net Profit Margin 14

  15. Slide 15: Financials – Balance Sheet

    Financials – Balance Sheet S$’ mil As at 30 Jun 2021 As at 31 Dec 2020 Net Assets 132.9 133.2 Borrowings - 4 Gearing1 (%) - 3 Cash & Cash Equivalents, Fixed 73.4 75.2 Deposits and Short-term Investments Net Asset Value Per Share (SG cents) 52.04 52.33 1: Total Borrowings/Total Equity 15

  16. Slide 16: Financials – Cash Flow

    Financials – Cash Flow S$’ mil As at 30 Jun 2021 As at 31 Jun 2020 Net cash generated from operating activities 4.4 6.7 Net cash (used in)/generated from investing (4.6) 1.6 activities Net cash used in financing activities (6.3) (0.2) Cash & cash equivalents at end of the 19.9 23.2 financial period

  17. Slide 17: Outlook & Growth Strategies

    Outlook & Growth Strategies 17

  18. Slide 18: Outlook

    Outlook Impact of COVID-19 Business Outlook – The Group managed to achieve stability in revenue over the past quarters by adapting quickly and pivoting with the evolving landscape. – The COVID-19 situation has generally resulted in the tapering of new customer sign-ups for banking services, and this

  19. Slide 19: Growth Strategies

    Growth Strategies Merger & Acquisitions

  20. Slide 20: Thank you

    Thank you 20

Cordlife Group — H1 2021 Earnings Presentation on 6ix